{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:08:19Z","timestamp":1785528499486,"version":"3.56.0"},"reference-count":36,"publisher":"China Science Publishing & Media Ltd.","issue":"2","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.3724\/abbs.2025117","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:31:14Z","timestamp":1751581874000},"page":"322-336","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K\/AKT signaling pathway via O-glycosylation of MUC13"],"prefix":"10.3724","volume":"58","author":[{"given":"Litao","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhou","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianbao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"CITATION1","doi-asserted-by":"crossref","unstructured":"Hepatocellular carcinoma.  Nat Rev Dis Primers  2021, 7: 7.","DOI":"10.1038\/s41572-021-00245-6"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41575-019-0229-4","volume":"17","author":"Craig AJ","year":"2020","unstructured":"Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol, 2020, 17: 139-152.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(18)30010-2","volume":"391","author":"Forner A","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet, 2018, 391: 1301-1314.","journal-title":"Lancet"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"Varki A","year":"2017","unstructured":"Varki A. Biological roles of glycans. Glycobiology, 2017, 27: 3-49.","journal-title":"Glycobiology"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"Pinho SS","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer, 2015, 15: 540-555.","journal-title":"Nat Rev Cancer"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41388-023-02702-w","volume":"42","author":"Wang Y","year":"2023","unstructured":"Wang Y, Chen H. Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. Oncogene, 2023, 42: 1970-1979.","journal-title":"Oncogene"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"103541","DOI":"10.1016\/j.ebiom.2021.103541","volume":"71","author":"Mohamed Abd-El-Halim Y","year":"2021","unstructured":"Mohamed Abd-El-Halim Y, El Kaoutari A, Silvy F, Rubis M, Bigonnet M, Roques J, Cros J. A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. eBioMedicine, 2021, 71: 103541.","journal-title":"eBioMedicine"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nchembio.2539","volume":"14","author":"Moremen KW","year":"2018","unstructured":"Moremen KW, Ramiah A, Stuart M, Steel J, Meng L, Forouhar F, Moniz HA. Expression system for structural and functional studies of human glycosylation enzymes. Nat Chem Biol, 2018, 14: 156-162.","journal-title":"Nat Chem Biol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/glycob\/cwr182","volume":"22","author":"Bennett EP","year":"2012","unstructured":"Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology, 2012, 22: 736-756.","journal-title":"Glycobiology"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41388-023-02604-x","volume":"42","author":"Scott E","year":"2023","unstructured":"Scott E, Hodgson K, Calle B, Turner H, Cheung K, Bermudez A, Marques FJG. Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth. Oncogene, 2023, 42: 926-937.","journal-title":"Oncogene"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12935-020-01209-8","volume":"20","author":"Cao Q","year":"2020","unstructured":"Cao Q, Wang N, Ren L, Tian J, Yang S, Cheng H. miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR\/PI3K\/AKT pathway. Cancer Cell Int, 2020, 20: 117.","journal-title":"Cancer Cell Int"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41419-023-06098-z","volume":"14","author":"Li J","year":"2023","unstructured":"Li J, Wan X, Xie D, Yuan H, Pei Q, Luo Y, Chen Y. SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer. Cell Death Dis, 2023, 14: 569.","journal-title":"Cell Death Dis"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.7150\/jca.65885","volume":"13","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Peng C, Li J, Zhang D, Zhang C, Jin K, Ji D. Long non-coding RNA CCDC144NL-AS1 promotes cell proliferation by regulating the miR-363-3p\/GALNT7 axis in colorectal cancer. J Cancer, 2022, 13: 752-763.","journal-title":"J Cancer"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-018-0632-2","volume":"11","author":"Li Y","year":"2018","unstructured":"Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B, Jia L. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K\/Akt\/mTOR pathway in colorectal cancer progression. J Hematol Oncol, 2018, 11: 89.","journal-title":"J Hematol Oncol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12935-021-02323-x","volume":"21","author":"Wang Y","year":"2021","unstructured":"Wang Y, Wang C, Fu Z, Zhang S, Chen J. miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR\/PI3K\/AKT pathway. Cancer Cell Int, 2021, 21: 618.","journal-title":"Cancer Cell Int"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1440-1746.2011.06909.x","volume":"27","author":"Sheng YH","year":"2012","unstructured":"Sheng YH, Hasnain SZ, Florin THJ, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastro Hepatol, 2012, 27: 28-38.","journal-title":"J Gastro Hepatol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.3390\/cells11223666","volume":"11","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Sun L, Lei C, Li W, Han J, Zhang J, Zhang Y. A sweet warning: mucin-type o-glycans in cancer. Cells, 2022, 11: 3666.","journal-title":"Cells"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.1074\/jbc.M008850200","volume":"276","author":"Williams SJ","year":"2001","unstructured":"Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. MUC13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem, 2001, 276: 18327-18336.","journal-title":"J Biol Chem"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/0008-5472.Can-08-0587","volume":"69","author":"Chauhan SC","year":"2009","unstructured":"Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, Pandey KK, Bell MC. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res, 2009, 69: 765-774.","journal-title":"Cancer Res"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s00535-013-0885-z","volume":"49","author":"Gupta BK","year":"2014","unstructured":"Gupta BK, Maher DM, Ebeling MC, Stephenson PD, Puumala SE, Koch MR, Aburatani H. Functions and regulation of MUC13 mucin in colon cancer cells. J Gastroenterol, 2014, 49: 1378-1391.","journal-title":"J Gastroenterol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/gut.2011.239194","volume":"60","author":"Sheng YH","year":"2011","unstructured":"Sheng YH, Lourie R, Linden SK, Jeffery PL, Roche D, Tran TV, Png CW. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut, 2011, 60: 1661-1670.","journal-title":"Gut"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ajpath.2017.10.016","volume":"188","author":"Dai Y","year":"2018","unstructured":"Dai Y, Liu L, Zeng T, Liang JZ, Song Y, Chen K, Li Y. Overexpression of MUC13, a poor prognostic predictor, promotes cell growth by activating wnt signaling in hepatocellular carcinoma. Am J Pathol, 2018, 188: 378-391.","journal-title":"Am J Pathol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/onc.2016.218","volume":"36","author":"Khan S","year":"2017","unstructured":"Khan S, Sikander M, Ebeling MC, Ganju A, Kumari S, Yallapu MM, Hafeez BB. MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. Oncogene, 2017, 36: 491-500.","journal-title":"Oncogene"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1515\/cclm-2022-0491","volume":"61","author":"Ren AH","year":"2023","unstructured":"Ren AH, Filippou PS, Soosaipillai A, Dimitrakopoulos L, Korbakis D, Leung F, Kulasingam V. Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes. Clin Chem Lab Med, 2023, 61: 464-472.","journal-title":"Clin Chem Lab Med"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1038\/s41388-019-0951-y","volume":"38","author":"Sheng Y","year":"2019","unstructured":"Sheng Y, Wong KY, Seim I, Wang R, He Y, Wu A, Patrick M. MUC13 promotes the development of colitis-associated colorectal tumors via \u03b2-catenin activity. Oncogene, 2019, 38: 7294-7310.","journal-title":"Oncogene"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2019.11.021","volume":"72","author":"Tiemin P","year":"2020","unstructured":"Tiemin P, Fanzheng M, Peng X, Jihua H, Ruipeng S, Yaliang L, Yan W. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR\/PI3K\/AKT pathways. J Hepatol, 2020, 72: 761-773.","journal-title":"J Hepatol"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/s0140-6736(18)30207-1","volume":"391","author":"Kudo M","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet, 2018, 391: 1163-1173.","journal-title":"Lancet"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"188806","DOI":"10.1016\/j.bbcan.2022.188806","volume":"1877","author":"Zhang J","year":"2022","unstructured":"Zhang J, Xun M, Li C, Chen Y. The O-GlcNAcylation and its promotion to hepatocellular carcinoma. Biochim Biophys Acta Rev Cancer, 2022, 1877: 188806.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.4049\/jimmunol.1901194","volume":"204","author":"Perkey E","year":"2020","unstructured":"Perkey E, Maurice De Sousa D, Carrington L, Chung J, Dils A, Granadier D, Koch U. GCNT1-mediated O-glycosylation of the Sialomucin CD43 is a sensitive indicator of notch signaling in activated T cells. J Immunol, 2020, 204: 1674-1688.","journal-title":"J Immunol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.7150\/ijbs.73431","volume":"18","author":"Zhang J","year":"2022","unstructured":"Zhang J, Wang H, Wu J, Yuan C, Chen S, Liu S, Huo M. GALNT1 enhances malignant phenotype of gastric cancer via modulating CD44 glycosylation to activate the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Sci, 2022, 18: 6068-6083.","journal-title":"Int J Biol Sci"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1158\/0008-5472.Can-09-3911","volume":"70","author":"Park JH","year":"2010","unstructured":"Park JH, Nishidate T, Kijima K, Ohashi T, Takegawa K, Fujikane T, Hirata K. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res, 2010, 70: 2759-2769.","journal-title":"Cancer Res"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/ijms20061288","volume":"20","author":"Kasprzak A","year":"2019","unstructured":"Kasprzak A, Adamek A. Mucins: the old, the new and the promising factors in hepatobiliary carcinogenesis. Int J Mol Sci, 2019, 20: 1288.","journal-title":"Int J Mol Sci"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-021-09959-1","volume":"40","author":"Marimuthu S","year":"2021","unstructured":"Marimuthu S, Rauth S, Ganguly K, Zhang C, Lakshmanan I, Batra SK, Ponnusamy MP. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. Cancer Metastasis Rev, 2021, 40: 575-588.","journal-title":"Cancer Metastasis Rev"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1158\/1541-7786.Mcr-10-0443","volume":"9","author":"Maher DM","year":"2011","unstructured":"Maher DM, Gupta BK, Nagata S, Jaggi M, Chauhan SC. Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol Cancer Res, 2011, 9: 531-537.","journal-title":"Mol Cancer Res"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"Paskeh MDA","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol Res, 2023, 187: 106553.","journal-title":"Pharmacol Res"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1038\/onc.2010.236","volume":"29","author":"Whittaker S","year":"2010","unstructured":"Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene, 2010, 29: 4989-5005.","journal-title":"Oncogene"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/1E54E8B3CC6C41479398811D1A33B18F","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025117","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/1E54E8B3CC6C41479398811D1A33B18F","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:23:52Z","timestamp":1770884632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025117","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}